Professor Delaney is a staff specialist in Radiation Oncology at Liverpool and Campbelltown Hospitals and the Director of Cancer Services for Sydney South West Area Health Service. His main clinical interest is breast cancer. He has research interests in health services-based research, minimising radiation error, the implementation of multidisciplinary care and health service delivery inequities in radiation therapy. He has published research in the international literature (over 150 peer-reviewed papers, reports and book chapters), and presented scientific papers and posters at national and international meetings. He has had significant involvement in policy decision making and planning of services through a number of committee responsibilities including committees for the National Breast and Ovarian Cancer Centre, NSW Cancer Institute, NSW Department of Health, Federal Government Dept of Health and Ageing, Royal Australian and New Zealand College of Radiologists and the NSW Cancer Council.

Professor Trevor Leong is Director of the Division of Radiation Oncology and Cancer Imaging at Peter MacCallum Cancer Centre. He is an active clinician researcher who is involved in both translational research programs as well as clinical research. He is internationally recognized as a leader in the management and research of upper GI cancers and has been a principal investigator in numerous phase I/II/III clinical trials relating to gastrointestinal malignancies, including oesophageal, gastric, anal and rectal cancer. Prof Leong is the Global Trial Chairperson for the current TOPGEAR randomised phase III trial in gastric cancer being conducted by the Australasian Gastro-Intestinal Trials Group (AGITG), TROG, EORTC and NCIC Clinical Trials Group that is recruiting patients from over 70 centres across 15 countries

Dr Mark Pinkham is a Radiation Oncologist based at the Princess Alexandra Hospital in Brisbane and a Senior Lecturer at the University of Queensland.  Having graduated from Oxford University in 2005, he completed specialist training in Brisbane in 2014 and then undertook an 18-month fellowship in neuro-oncology and intracranial stereotactic radiosurgery at the Christie Hospital, UK. He was appointed as a Staff Specialist in 2015 and is part of the Gamma Knife ® Centre of Queensland which is the first public service of its kind in Australia.  His main clinical and research interests are in the treatment of diseases of the central nervous system including brain metastases and melanoma.

Dr Sandro Porceddu is a full-time Senior Radiation Oncologist and Director of Radiation Oncology Research at the Princess Alexandra Hospital, Brisbane and Associate Professor with the University of Queensland. His areas of clinical expertise are Head and Neck Cancer, Skin Cancer and Lymphoma. He is the immediate past President of the Trans Tasman Radiation Oncology Group (TROG), former president of the Clinical Oncology Society of Australia (COSA), and founding member of the NCI-sponsored Head and Neck Cancer Intergroup (HNCIG). He has led a number of clinical trials, published widely in peer-review journals and is currently associate editor of Oral Oncology. He sits on a number of international committees, including the UICC TNM expert panel.

A/Prof Shalini Vinod is a senior staff specialist radiation oncologist, and Conjoint Associate Professor at the University of New South Wales and Western Sydney University. She leads the Lung Cancer Multidisciplinary Team across Liverpool and Macarthur Cancer Therapy Centres. A/Prof Vinod is actively involved in research and has over 60 peer-reviewed publications and numerous conference presentations. She subspecialises in the treatment of lung and breast cancers. She is a contributing author of the Australian Clinical Practice Guidelines for lung cancer as well as eviQ guidelines. She is on the trial management committee for two multicenter Trans Tasman Radiation Oncology Group (TROG) trials and a member of the TROG Thoracic Oncology Group. She is chair of the Faculty of Radiation Oncology Lung Interest Cooperative (FROLIC), a subspecialty interest group within RANZCR, devoted to facilitating best practice radiation therapy and collaborative research for thoracic malignancies.

Dr Amy Hayden  is a Radiation Oncologist at Sydney West Radiation Oncology Network, Westmead.  Having graduated from University of New South Wales in 2000, she completed specialist training in 2008, and was awarded the RANZCR medal for performance in the fellowship examinations.  Dr Hayden then undertook a prostate cancer clinical research fellowship at the BC Cancer Agency, Vancouver.  Amy is a member of the Faculty of Radiation Oncology Genito-urinary Group executive, and was the first author of the Australian & New Zealand guidelines on definitive radiotherapy for prostate cancer in 2010. She is an active member of TROG and ANZUP, and is a site investigator for multiple clinical trials.  She has an interest in stereotactic radiotherapy and has recently commenced a prostate stereotactic radiotherapy programme as part of the TROG SPARK trial.  Amy is a member of the multidisciplinary uro-oncology team at Westmead and Nepean Hospitals.  Her main clinical and research interests are in the treatment of prostate cancer and other urological malignancies.

Assoc/Prof Margot Lehman is the Acting Director of Radiation oncology, Princess Alexandra Hospital.  Her interests include the management of lung, GU and breast malignancies.  She has contributed to Cancer Australia and eviQ guidelines.  She is currently the Chief Censor of the Faculty of radiation oncology.